ESTRO24
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
ESTRO24
Sep 1, 2024, 14:45 |
Insight
Brachytherapy and interventional radiotherapy report at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "Read the latest…
Aug 26, 2024, 06:20 |
Blog
SBRT in Prostate Cancer at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "Five-year outcomes from…
Aug 25, 2024, 13:17 |
Insight
Rebecca Muirhead on the evolving landscape of rectal cancer treatment at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "Explore the evolving…
Aug 25, 2024, 08:59 |
Blog
Trials in gynaecological cancers presented at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "Check out the trials in…
Aug 17, 2024, 12:32 |
Blog
Latest advancements in FLASH radiotherapy from ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "Latest advancements in FLASH radiotherapy…
Aug 15, 2024, 18:54 |
Blog
ESTRO24 Highlights in radiobiology and SBRT
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "ESTRO24 Highlights in…
Aug 12, 2024, 11:33 |
Insight
MRI-compatible deformable phantom with integrated PSDs at ESTRO
European SocieTy for Radiotherapy and Oncology (ESTRO) shared on X: “Check out this ESTRO24 study…
Aug 9, 2024, 09:40 |
Blog
Dosimetry highlights from ESTRO24
European Society for Radiotherapy and Oncology posted on LinkedIn: …
Aug 8, 2024, 02:42 |
Blog
Insights from the ESTRO24 symposium on upright radiotherapy
European Society for Radiotherapy and Oncology, shared a post on LinkedIn: “Latest insights from the ESTRO24…
Aug 6, 2024, 16:48 |
Insight
Findings from key trials SC.24 and RTOG 0631 and influence SBRT's effectiveness - European Society for Radiotherapy and Oncology
European Society for Radiotherapy and Oncology, shared a post on LinkedIn: "Although some guidelines support…
Aug 5, 2024, 18:16 |
Blog
20 abstracts on prostate brachytherapy were selected for presentation at ESTRO24
ESTRO (European Society for Radiotherapy and Oncology) shared a post on LinkedIn: ''20 abstracts on…
Aug 2, 2024, 12:21 |
Blog
Session Highlights on Irradiation Volume and SBRT Optimisation at ESTRO24
ESTRO (European Society for Radiotherapy and Oncology) shared a post on LinkedIn: ''Comprehensive report on…
Jul 29, 2024, 23:26 |
Insight
Latest insights on targeting metabolism to enhance radiotherapy efficacy - European Society for Radiotherapy and Oncology
European Society for Radiotherapy and Oncology, shared a post on LinkedIn: "Dive into the world…
Jul 27, 2024, 14:41 |
Blog
The winner of the Physics Best Paper Award at ESTRO24
ESTRO shared a post on X: "Presentation of contents of the winner of the Physics…
Jul 25, 2024, 23:48 |
Blog
ESTRO - To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?
European Society for Radiotherapy and Oncology shared on LinkedIn: "Key insights from ESTRO24 on the optimisation…
Jul 25, 2024, 08:21 |
Insight
5-year results of the hypo-FLAME trial on focal boost SBRT for prostate cancer - ESTRO
European Society for Radiotherapy and Oncology (ESTRO) shared a post on X: "5-year results of…
Jul 23, 2024, 10:54 |
Insight
Highlights from the lower GI proffered papers session at ESTRO24
European SocieTy for Radiotherapy and Oncology (ESTRO) shared on X: “Latest advances in rectal cancer…
Jul 10, 2024, 06:47 |
Insight
The latest results from the PACE-C trial presented at ESTRO24
ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X: . "Check out…
Jul 7, 2024, 08:39 |
Blog
Multi-disciplinary management of anal cancer - ESTRO
ESTRO shared a post on X: “Latest updates on the multi-disciplinary management of anal cancer…
Jul 6, 2024, 11:24 |
Blog
Insights from ESTRO24 on reirradiation in NSCLC by Jonas Willmann
European Society for Radiotherapy and Oncology shared on X: "Insights from ESTRO24 on reirradiation in NSCLC…
Jul 5, 2024, 01:49 |
Insight
Highlights of the RADIOSA phase II trial presented at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared a paper on LinkedIn: "Highlights of the…
Jul 3, 2024, 08:33 |
Blog
TipsRO Young Researcher Award at ESTRO24 - European Society for Radiotherapy and Oncology
European Society for Radiotherapy and Oncology (ESTRO) shared a post on X: “TipsRO Young Researcher…
Jun 10, 2024, 12:19 |
Insight
Results from the TRAP trial presented at ESTRO24
ESTRO shared on X/Twitter: "Results from the TRAP trial presented at ESTRO24: this phase-II trial explores…
May 15, 2024, 09:29 |
Blog
Reflecting on the General Assembly at ESTRO24
ESTRO shared on /Twitter: "What a momentous gathering! Reflecting on the General Assembly at ESTRO24, where…
May 11, 2024, 13:18 |
Career
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "We're thrilled to announce the…
May 8, 2024, 02:11 |
Blog
Piet Ost: RADIOSA trial at ESTRO24
Piet Ost, Assistant Professor of Radiation Oncology at Ghent University, shared on X/Twitter: "RADIOSA trial: oligorecurrent…
May 8, 2024, 02:03 |
Blog
Nat Lester-Coll: Prostate SBRT with empty bladder - challenging the dogma
Nat Lester-Coll, Radiation oncologist at UVM Medical Center, shared on X/Twitter: "ESTRO24 Prostate SBRT with empty…
All:
27
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube